Larraitz Egaña Otaño

Dr. Larraitz Egaña Otaño is a renowned medical oncologist currently practicing at the Policlínica Gipuzkoa , specializing in medical oncology . Her academic background includes a degree in Medicine and Surgery from the Universidad del País Vasco, complemented by a doctoral thesis on the prognostic and predictive value of the response to temozolomide in high-grade gliomas. Among her contributions to the field of oncology is her publication in Scientific Reports, entitled "Methylation of MGMT promoter does not predict response to temozolomide in patients with glioblastoma in Donostia Hospital." Furthermore, Dr. Egaña Otaño is a member of the Spanish Neuro-oncology Research Group (GEINO), which underscores her commitment to research and advancing the treatment of brain tumors.